0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Polymer Vials Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-18M17277
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Polymer Vials Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Polymer Vials Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-18M17277
Report
October 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Polymer Vials Market

The global Pharmaceutical Polymer Vials market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Injectable Drugs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Polymer Vials leading manufacturers including Bormioli Pharma, Nipro, Piramal Glass, Corning, DWK Life Sciences, APG, Gerresheimer, SCHOTT, Berry Global, West Pharmaceutical Services, etc., dominate supply; the top five capture approximately % of global revenue, with Bormioli Pharma leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Polymer Vials market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceutical Polymer Vials Market Report

Report Metric Details
Report Name Pharmaceutical Polymer Vials Market
Segment by Type
  • Nipple Bottle
  • Double Chambered Bottle
  • Threaded Bottle
  • Other
Segment by Application
  • Injectable Drugs
  • Oral Liquid
  • Biological Agent
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bormioli Pharma, Nipro, Piramal Glass, Corning, DWK Life Sciences, APG, Gerresheimer, SCHOTT, Berry Global, West Pharmaceutical Services, Origin Pharma Packaging, SGD Pharma, Pacific Vial, Stevanato
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceutical Polymer Vials study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceutical Polymer Vials Market report?

Ans: The main players in the Pharmaceutical Polymer Vials Market are Bormioli Pharma, Nipro, Piramal Glass, Corning, DWK Life Sciences, APG, Gerresheimer, SCHOTT, Berry Global, West Pharmaceutical Services, Origin Pharma Packaging, SGD Pharma, Pacific Vial, Stevanato

What are the Application segmentation covered in the Pharmaceutical Polymer Vials Market report?

Ans: The Applications covered in the Pharmaceutical Polymer Vials Market report are Injectable Drugs, Oral Liquid, Biological Agent, Other

What are the Type segmentation covered in the Pharmaceutical Polymer Vials Market report?

Ans: The Types covered in the Pharmaceutical Polymer Vials Market report are Nipple Bottle, Double Chambered Bottle, Threaded Bottle, Other

1 Study Coverage
1.1 Introduction to Pharmaceutical Polymer Vials: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Polymer Vials Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nipple Bottle
1.2.3 Double Chambered Bottle
1.2.4 Threaded Bottle
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Polymer Vials Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable Drugs
1.3.3 Oral Liquid
1.3.4 Biological Agent
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Polymer Vials Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Polymer Vials Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Polymer Vials Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Polymer Vials Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pharmaceutical Polymer Vials Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pharmaceutical Polymer Vials Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Nipple Bottle Market Size by Manufacturers
3.5.2 Double Chambered Bottle Market Size by Manufacturers
3.5.3 Threaded Bottle Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Pharmaceutical Polymer Vials Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Polymer Vials Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Polymer Vials Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Polymer Vials Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pharmaceutical Polymer Vials Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
6.4 North America Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Polymer Vials Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
7.4 Europe Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Polymer Vials Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pharmaceutical Polymer Vials Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Polymer Vials Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Polymer Vials Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bormioli Pharma
11.1.1 Bormioli Pharma Corporation Information
11.1.2 Bormioli Pharma Business Overview
11.1.3 Bormioli Pharma Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.1.4 Bormioli Pharma Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Product in 2024
11.1.6 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Application in 2024
11.1.7 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.1.8 Bormioli Pharma Pharmaceutical Polymer Vials SWOT Analysis
11.1.9 Bormioli Pharma Recent Developments
11.2 Nipro
11.2.1 Nipro Corporation Information
11.2.2 Nipro Business Overview
11.2.3 Nipro Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.2.4 Nipro Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Nipro Pharmaceutical Polymer Vials Sales by Product in 2024
11.2.6 Nipro Pharmaceutical Polymer Vials Sales by Application in 2024
11.2.7 Nipro Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.2.8 Nipro Pharmaceutical Polymer Vials SWOT Analysis
11.2.9 Nipro Recent Developments
11.3 Piramal Glass
11.3.1 Piramal Glass Corporation Information
11.3.2 Piramal Glass Business Overview
11.3.3 Piramal Glass Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.3.4 Piramal Glass Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Piramal Glass Pharmaceutical Polymer Vials Sales by Product in 2024
11.3.6 Piramal Glass Pharmaceutical Polymer Vials Sales by Application in 2024
11.3.7 Piramal Glass Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.3.8 Piramal Glass Pharmaceutical Polymer Vials SWOT Analysis
11.3.9 Piramal Glass Recent Developments
11.4 Corning
11.4.1 Corning Corporation Information
11.4.2 Corning Business Overview
11.4.3 Corning Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.4.4 Corning Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Corning Pharmaceutical Polymer Vials Sales by Product in 2024
11.4.6 Corning Pharmaceutical Polymer Vials Sales by Application in 2024
11.4.7 Corning Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.4.8 Corning Pharmaceutical Polymer Vials SWOT Analysis
11.4.9 Corning Recent Developments
11.5 DWK Life Sciences
11.5.1 DWK Life Sciences Corporation Information
11.5.2 DWK Life Sciences Business Overview
11.5.3 DWK Life Sciences Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.5.4 DWK Life Sciences Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Product in 2024
11.5.6 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Application in 2024
11.5.7 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.5.8 DWK Life Sciences Pharmaceutical Polymer Vials SWOT Analysis
11.5.9 DWK Life Sciences Recent Developments
11.6 APG
11.6.1 APG Corporation Information
11.6.2 APG Business Overview
11.6.3 APG Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.6.4 APG Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 APG Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Business Overview
11.7.3 Gerresheimer Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.7.4 Gerresheimer Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Gerresheimer Recent Developments
11.8 SCHOTT
11.8.1 SCHOTT Corporation Information
11.8.2 SCHOTT Business Overview
11.8.3 SCHOTT Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.8.4 SCHOTT Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SCHOTT Recent Developments
11.9 Berry Global
11.9.1 Berry Global Corporation Information
11.9.2 Berry Global Business Overview
11.9.3 Berry Global Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.9.4 Berry Global Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Berry Global Recent Developments
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Corporation Information
11.10.2 West Pharmaceutical Services Business Overview
11.10.3 West Pharmaceutical Services Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.10.4 West Pharmaceutical Services Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 West Pharmaceutical Services Recent Developments
11.11 Origin Pharma Packaging
11.11.1 Origin Pharma Packaging Corporation Information
11.11.2 Origin Pharma Packaging Business Overview
11.11.3 Origin Pharma Packaging Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.11.4 Origin Pharma Packaging Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Origin Pharma Packaging Recent Developments
11.12 SGD Pharma
11.12.1 SGD Pharma Corporation Information
11.12.2 SGD Pharma Business Overview
11.12.3 SGD Pharma Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.12.4 SGD Pharma Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 SGD Pharma Recent Developments
11.13 Pacific Vial
11.13.1 Pacific Vial Corporation Information
11.13.2 Pacific Vial Business Overview
11.13.3 Pacific Vial Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.13.4 Pacific Vial Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Pacific Vial Recent Developments
11.14 Stevanato
11.14.1 Stevanato Corporation Information
11.14.2 Stevanato Business Overview
11.14.3 Stevanato Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.14.4 Stevanato Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Stevanato Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pharmaceutical Polymer Vials Industry Chain
12.2 Pharmaceutical Polymer Vials Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pharmaceutical Polymer Vials Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pharmaceutical Polymer Vials Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Polymer Vials Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Polymer Vials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceutical Polymer Vials Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceutical Polymer Vials Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pharmaceutical Polymer Vials Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Pharmaceutical Polymer Vials Sales by Region (2020-2025) & (K Units)
 Table 8. Global Pharmaceutical Polymer Vials Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pharmaceutical Polymer Vials Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Pharmaceutical Polymer Vials Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pharmaceutical Polymer Vials Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pharmaceutical Polymer Vials Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pharmaceutical Polymer Vials by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Polymer Vials as of 2024)
 Table 16. Global Pharmaceutical Polymer Vials Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pharmaceutical Polymer Vials Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Pharmaceutical Polymer Vials Manufacturing Base and Headquarters
 Table 19. Global Pharmaceutical Polymer Vials Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pharmaceutical Polymer Vials Sales by Type (2020-2025) & (K Units)
 Table 23. Global Pharmaceutical Polymer Vials Sales by Type (2026-2031) & (K Units)
 Table 24. Global Pharmaceutical Polymer Vials Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceutical Polymer Vials Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical Polymer Vials ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pharmaceutical Polymer Vials Sales by Application (2020-2025) & (K Units)
 Table 29. Global Pharmaceutical Polymer Vials Sales by Application (2026-2031) & (K Units)
 Table 30. Pharmaceutical Polymer Vials High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pharmaceutical Polymer Vials Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pharmaceutical Polymer Vials Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pharmaceutical Polymer Vials ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
 Table 37. North America Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
 Table 40. Europe Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pharmaceutical Polymer Vials Investment Opportunities and Key Challenges
 Table 47. Central and South America Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pharmaceutical Polymer Vials Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Bormioli Pharma Corporation Information
 Table 51. Bormioli Pharma Description and Major Businesses
 Table 52. Bormioli Pharma Product Models, Descriptions and Specifications
 Table 53. Bormioli Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Bormioli Pharma Sales Value Proportion by Product in 2024
 Table 55. Bormioli Pharma Sales Value Proportion by Application in 2024
 Table 56. Bormioli Pharma Sales Value Proportion by Geographic Area in 2024
 Table 57. Bormioli Pharma Pharmaceutical Polymer Vials SWOT Analysis
 Table 58. Bormioli Pharma Recent Developments
 Table 59. Nipro Corporation Information
 Table 60. Nipro Description and Major Businesses
 Table 61. Nipro Product Models, Descriptions and Specifications
 Table 62. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Nipro Sales Value Proportion by Product in 2024
 Table 64. Nipro Sales Value Proportion by Application in 2024
 Table 65. Nipro Sales Value Proportion by Geographic Area in 2024
 Table 66. Nipro Pharmaceutical Polymer Vials SWOT Analysis
 Table 67. Nipro Recent Developments
 Table 68. Piramal Glass Corporation Information
 Table 69. Piramal Glass Description and Major Businesses
 Table 70. Piramal Glass Product Models, Descriptions and Specifications
 Table 71. Piramal Glass Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Piramal Glass Sales Value Proportion by Product in 2024
 Table 73. Piramal Glass Sales Value Proportion by Application in 2024
 Table 74. Piramal Glass Sales Value Proportion by Geographic Area in 2024
 Table 75. Piramal Glass Pharmaceutical Polymer Vials SWOT Analysis
 Table 76. Piramal Glass Recent Developments
 Table 77. Corning Corporation Information
 Table 78. Corning Description and Major Businesses
 Table 79. Corning Product Models, Descriptions and Specifications
 Table 80. Corning Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Corning Sales Value Proportion by Product in 2024
 Table 82. Corning Sales Value Proportion by Application in 2024
 Table 83. Corning Sales Value Proportion by Geographic Area in 2024
 Table 84. Corning Pharmaceutical Polymer Vials SWOT Analysis
 Table 85. Corning Recent Developments
 Table 86. DWK Life Sciences Corporation Information
 Table 87. DWK Life Sciences Description and Major Businesses
 Table 88. DWK Life Sciences Product Models, Descriptions and Specifications
 Table 89. DWK Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. DWK Life Sciences Sales Value Proportion by Product in 2024
 Table 91. DWK Life Sciences Sales Value Proportion by Application in 2024
 Table 92. DWK Life Sciences Sales Value Proportion by Geographic Area in 2024
 Table 93. DWK Life Sciences Pharmaceutical Polymer Vials SWOT Analysis
 Table 94. DWK Life Sciences Recent Developments
 Table 95. APG Corporation Information
 Table 96. APG Description and Major Businesses
 Table 97. APG Product Models, Descriptions and Specifications
 Table 98. APG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. APG Recent Developments
 Table 100. Gerresheimer Corporation Information
 Table 101. Gerresheimer Description and Major Businesses
 Table 102. Gerresheimer Product Models, Descriptions and Specifications
 Table 103. Gerresheimer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Gerresheimer Recent Developments
 Table 105. SCHOTT Corporation Information
 Table 106. SCHOTT Description and Major Businesses
 Table 107. SCHOTT Product Models, Descriptions and Specifications
 Table 108. SCHOTT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. SCHOTT Recent Developments
 Table 110. Berry Global Corporation Information
 Table 111. Berry Global Description and Major Businesses
 Table 112. Berry Global Product Models, Descriptions and Specifications
 Table 113. Berry Global Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Berry Global Recent Developments
 Table 115. West Pharmaceutical Services Corporation Information
 Table 116. West Pharmaceutical Services Description and Major Businesses
 Table 117. West Pharmaceutical Services Product Models, Descriptions and Specifications
 Table 118. West Pharmaceutical Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. West Pharmaceutical Services Recent Developments
 Table 120. Origin Pharma Packaging Corporation Information
 Table 121. Origin Pharma Packaging Description and Major Businesses
 Table 122. Origin Pharma Packaging Product Models, Descriptions and Specifications
 Table 123. Origin Pharma Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Origin Pharma Packaging Recent Developments
 Table 125. SGD Pharma Corporation Information
 Table 126. SGD Pharma Description and Major Businesses
 Table 127. SGD Pharma Product Models, Descriptions and Specifications
 Table 128. SGD Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. SGD Pharma Recent Developments
 Table 130. Pacific Vial Corporation Information
 Table 131. Pacific Vial Description and Major Businesses
 Table 132. Pacific Vial Product Models, Descriptions and Specifications
 Table 133. Pacific Vial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Pacific Vial Recent Developments
 Table 135. Stevanato Corporation Information
 Table 136. Stevanato Description and Major Businesses
 Table 137. Stevanato Product Models, Descriptions and Specifications
 Table 138. Stevanato Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Stevanato Recent Developments
 Table 140. Key Raw Materials Distribution
 Table 141. Raw Materials Key Suppliers
 Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 143. Milestones in Production Technology Evolution
 Table 144. Distributors List
 Table 145. Market Trends and Market Evolution
 Table 146. Market Drivers and Opportunities
 Table 147. Market Challenges, Risks, and Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Polymer Vials Product Picture
 Figure 2. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Nipple Bottle Product Picture
 Figure 4. Double Chambered Bottle Product Picture
 Figure 5. Threaded Bottle Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Injectable Drugs
 Figure 9. Oral Liquid
 Figure 10. Biological Agent
 Figure 11. Other
 Figure 12. Pharmaceutical Polymer Vials Report Years Considered
 Figure 13. Global Pharmaceutical Polymer Vials Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Pharmaceutical Polymer Vials Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Pharmaceutical Polymer Vials Revenue Market Share by Region (2020-2031)
 Figure 17. Global Pharmaceutical Polymer Vials Sales (2020-2031) & (K Units)
 Figure 18. Global Pharmaceutical Polymer Vials Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Pharmaceutical Polymer Vials Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Pharmaceutical Polymer Vials Sales Volume Market Share in 2024
 Figure 21. Global Pharmaceutical Polymer Vials Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Nipple Bottle Revenue Market Share by Manufacturer in 2024
 Figure 24. Double Chambered Bottle Revenue Market Share by Manufacturer in 2024
 Figure 25. Threaded Bottle Revenue Market Share by Manufacturer in 2024
 Figure 26. Other Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Pharmaceutical Polymer Vials Sales Market Share by Type (2020-2031)
 Figure 28. Global Pharmaceutical Polymer Vials Revenue Market Share by Type (2020-2031)
 Figure 29. Global Pharmaceutical Polymer Vials Sales Market Share by Application (2020-2031)
 Figure 30. Global Pharmaceutical Polymer Vials Revenue Market Share by Application (2020-2031)
 Figure 31. North America Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
 Figure 32. North America Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
 Figure 34. North America Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020- 2031)
 Figure 35. North America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
 Figure 37. North America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
 Figure 42. Europe Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020-2031)
 Figure 45. Europe Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
 Figure 47. Europe Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 49. France Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
 Figure 54. Asia-Pacific Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 64. India Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
 Figure 66. Central and South America Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2021-2031)
 Figure 69. Central and South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
 Figure 71. Central and South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
 Figure 75. Middle East and Africa Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2021-2031)
 Figure 78. South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
 Figure 85. Pharmaceutical Polymer Vials Industry Chain Mapping
 Figure 86. Regional Pharmaceutical Polymer Vials Manufacturing Base Distribution (%)
 Figure 87. Global Pharmaceutical Polymer Vials Production Market Share by Region (2020-2031)
 Figure 88. Pharmaceutical Polymer Vials Production Process
 Figure 89. Regional Pharmaceutical Polymer Vials Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India